Value Microcaps Zip Code Changers

[Potse]

db7...regarding VODG.....

Potse, VODG update, lots of irons in the fire: investorshub.advfn.com/boards/read_msg.aspx?message_id=104981647

I think there is a pretty good possibility of seeing at least one solid move/push above the 30 cent area sometime in the next 6 months or so. Q3 is complete (May-July), so that quarterly report should be coming out sometime next month.

I'm semi-expecting to see a number of potentially interesting press releases and/or developments between now and the end of calendar 2015. Things appear to picking up some steam on the business opportunity side. I'm still hoping to see VODG and James Posillico enter into some type of agreement/collaboration regarding VODG's wound care product(s). That has the potential of raising a few eyebrows, IMO.

VODG is probably overdue for some type of uncompensated promotion. It seems the promoters have been targeting VODG about once a year over the last couple/few years, and with the current/future developments at VODG the stock will probably start attracting attention again.

Looking out into 2015 and beyond: If/when VODG, Neuromics, and/or Hemogenix decide to merge their companies, another potential acquisition target might be another Minnesota-based company (ImmunoChemistry Technologies). Neuromics CEO Pete Shuster has worked with that company for about a decade or so, and the company has some pretty interesting products/technology. If I recall correctly, based on some social media statments Shuster made last year, when Joseph Smarda came to Minnesota last year to meet with Shuster and VODG CEO James Musick, they also met with the people from ImmunoChemistry at or around the same.

http://www.immunochemistry.com/